Nitric oxide plays an important role in stem cell differentiation and in endothelial cells it is expressed by endothelial nitric oxide synthase (eNOS) which is located within membrane caveolae through scaffolding with caveolin-1 (CAV-1WT) which inhibits NO production. In this study, we modified rat bone marrow mesenchymal stem cells (rBMSCs) with lentiviral vectors to co-express eNOS and mutant caveolin-1 (CAV-1F92A) to enhance NO generation and investigated endothelial reprogramming. A lenti-eNOS-GFP fusion vector which allowed FACS selection of eNOS positive cells increased NO production (6.9 ± 0.8 μM) compared to GFP alone (1.04 ± 0.22 μM) and un-transduced cells (0.91± 0.35 μM) (pb0.05). eNOS-GFP and GFP cells were further re-transduced with CAV-1F92A or CAV-1WT. rBMSCeNOS+ CAV-1F92A showed enhanced in vitro capillary tubule formation, upregulation of endothelial specific CD31, V-cadherin gene expression which was reversed by treatment with the eNOS inhibitor L-NAME. Activity of an endothelial specific FLT1-eGFP lentiviral-reporter was also increased compared to controls. Furthermore, arterial specific Notch1, Hey 1 and DII4 gene expression was increased in rBMSCeNOS+ CAV-1F92A whereas venous specific COUP-TFII and lymphatic specific Prox1 expression was significantly reduced. Canonical Wnt3A gene expression was increased in rBMSCeNOS +CAV-1F92A and treatment with L-NAME, resulted in reduced CD31 and Wnt3A expression, and the Wnt inhibitor Dkk-1 also decreased CD31 expression. Western blot analysis showed increased β-catenin expression in rBMSCeNOS +CAV-1F92A confirming the relationship between NO and Wnt/β-catenin signaling. Furthermore rBMSCeNOS+CAV-1F92A cells showed decreased histone deacytaylase SIRT6 and DNA methyltransferase DNMT1 expression which was reversed with L-NAME treatment highlighting that NO may drive epigenetic modification during reprogramming. Finally, subcutaneous implantation of the rBMSCeNOS +CAV-1F92A cells seeded in polyurethane scaffolds in rats, resulted in formation of blood vessels. In summary, our data suggest that nitric oxide activates Wnt/-β-catenin signaling to promote endothelial reprogramming of BMSCs and may provide a novel platform for vascular repair. The homeodomain transcription factor NKX2-5 is essential for the development and normal physiology of the vertebrate heart. However, despite extensive analyses, the direct downstream effectors of NKX2.5 function during the differentiation of cardiac progenitor cells (CPCs) are largely unknown. We have identified Furin, which is coding for a proprotein convertase, as a direct transcriptional target of NKX2-5 and studied its role during cardiac development.
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Using a genome wide distribution approach we found a region close to the Furin gene enriched for NKX2-5 binding. That region is able to drive LacZ expression in a transgenic mouse assay in a pattern comparable to that of the endogenous Furin. On a Nkx2-5 null mutant background, the expression of the Furin-enhancer-LacZ transgene is upregulated in the heart in a similar way as the endogenous Furin mRNA is in the same mutant embryos. Moreover, heart expression of endogenous Furin is downregulated when that enhancer is deleted in a mutant mouse model. Taken together those results show that we have identified a cardiac enhancer of Furin, directly repressed by NKX2-5.
To assess the function of Furin we specifically deleted its expression in CPCs using a conditional mouse knockout. Cardiomyocyte specific mutant embryos for Furin show a whole series of cardiac abnormalities including ventricular septal defect and a range of defects in the outflow tract formation. Moreover, premature expression of cardiac differentiation markers in the CPCs of the anterior heart field of the mutant embryos suggests a role for Furin in the differentiation of those cells. Twist1 encodes a basic helix-loop-helix domain (bHLH) transcription factor that regulates the differentiation of cranial neural crest and head mesoderm during craniofacial development. To gain insight into the transcriptional network in which TWIST1 operates, we identified TWIST1 interacting proteins in mouse neural crest stem cells and fibroblasts. Using the BioID proteomic approach, we were able to capture the persistent as well as transient interaction between transcription factors and protein partners. For the BioID analysis, TWIST1 was fused to the BirA* biotin ligase that will biotinylate TWIST1 interacting proteins in the native condition and a cellular environment. The biotinylated proteins were then captured by streptavidin beads and processed for mass-spectrometry identification. Bioinformatics analysis of the proteomic data from three cell lines and cross comparison with public datasets revealed both known and potentially novel interacting partners of TWIST1. Followup network analysis of the TWIST1 interactome identified interaction hubs featuring transcription factors and chromatin modifiers. Mutations of many of these interacting partners are associated with human syndromes that share the phenotypic overlap with SaethreChotzen Syndrome (linked to TWIST1 mutations) in the craniofacial region. We further mapped the gene regulatory network of TWIST1 and its partners through the analysis of our transcriptome data on TWIST1 downstream genes in the craniofacial tissues, and our and public ChIP-seq datasets of TWIST1 and the interacting partner in other cell models. Currently we are generating, using the CRISPR technology, embryos from double heterozygote knock-out embryonic stem cells to assess the role of the TWIST1-protein complexes in craniofacial development. High fidelity orchestration of gene expression during development requires precise temporal and spatial control mechanisms. Distal regulatory elements are thought to function via co-localization with the promoters they regulate, resulting in the formation of specific three-dimensional conformations within the nucleus that facilitate the molecular steps required for gene activation.
At the Sox21 locus, 19 conserved cis -regulatory elements have been identified, which drive expression in reporter assays, making them suitable candidates for possible interaction partners with the promoter region.
Reporter assays in zebrafish embryos suggest that they have an enhancer function, in part in individual tissues, but also some of the CNEs enhancers overlapping function in one tissue.
To determine whether the conserved non-coding elements are directly interacting with the promoter region or if they are preferentially interacting with other parts of the locus we have performed chromosome conformation capture.
Our results in tissue culture suggests that one of the conserved non -coding elements interact directly with promoter regions, which supports the model that individual CNEs are functioning as enhancers.
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Epigenetic modifications, such as DNA methylation and histone modifications, are thought to activate or repress gene expression, resulting in the change of developmental or differential process. For example, in the chromatin silencing process caused by Polycomb repressive complex (PRC), the PRC2 methyltransferase Ezh2 induces H3K27me3, and then PRC1 is recruited to H2K27me3 and compacts the chromatin, which leads to silencing. As a result, some of the somatic lineages cannot start differentiation because of the H3K27me3 at the developmental promoters.
In recent years, next generation sequence techniques revealed the dynamic epigenetic change and correlation between epigenetic modification and expression states at each regulatory element, such as promoters and enhancers in each developmental stage. However, the direct relationship between epigenetic modifications and gene expression at each genomic locus was not fully understood because of the difficulty of the targeted modification manipulation. Furthermore, whether epigenetic modifications are heritable from mother cells to daughter cells or from parents (F0) to offspring (F1) is little to be tested.
Recently, CRISPR-based epigenome editing method was established, and it enables site-specific epigenome manipulations. In this technology, enzymes fused to nuclease-null Cas9 (dCas9) are recruited to targets by sgRNA and alter epigenetic modifications. However, the numbers of editable epigenetic modifications are still limited, and there are little in vivo epigenome editing experiments. In this study, we fused repressive histone methyltransferase Ezh2 to dCas9, and induced H3K27me3 site-specifically in vivo in medaka fish embryo by microinjection. We also show the gene activation in medaka using dCas9-p300. These in vivo epigenome editing will help future researches of direct function of histone modifications in each genomic region and investigation of histone modification heritability.
On the other hand, in the process of activation, H3K27 acetyltransferase p300 and CBP are recruited to repressed chromatin and induce H3K27ac, which causes chromatin opening and enables Pol2 access. Zhejiang University, Hangzhou, China DNA topoisomerases modulate DNA topology to maintain chromosome superstructure and genome integrity, facilitating DNA replication and RNA transcription. However, their function in plant development is still largely unclear. Here we report a hitherto unidentified role of Topoisomerase Iα (TOP1α) in regulating flowering time in Arabidopsis thaliana. Loss of function of TOP1α leads to an early flowering phenotype under both long and short days. This is mainly attributed to the down-regulation of a central flowering repressor FLOWERING LOCUS C (FLC) and its closed homologs, MADS AFFECTING FLOWERING 4/5 (MAF4 and MAF5), during the floral transition. TOP1α physically binds to the genomic regions of FLC, MAF4 and MAF5, and promotes the association of RNA polymerase II complexes to their transcriptional start sites in correlation with the changes of histone modifications at these gene loci. Our results suggest that TOP1α mediates DNA topology to promote the recruitment of RNA polymerase II at FLC, MAF4 and MAF5, thus activating the expression of these key flowering repressors to prevent precocious flowering in Arabidopsis.
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